Cited by 28Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and DisordersGenomics and Rare Diseases

A highly sensitive, high-throughput assay for the detection of Turner syndrome

Open access
Rivkees, Scott A., Hager, Karl, Hosono, Seiyu, Wise, Anastasia, Li, Peining, Rinder, Henry M., Gruen, Jeffrey R.·2011·The Journal of Clinical Endocrinology & Metabolism

Abstract

OBJECTIVE: Turner syndrome (TS) occurs when an X-chromosome is completely or partially deleted or when X-chromosomal mosaicism is present. Girls with TS benefit from early diagnosis and treatment with GH; however, many girls with TS are not detected until after 10 yr of age, resulting in delayed evaluation and treatment. METHODS: We developed a high-throughput test for TS, based on a quantitative method of genotyping to detect X-chromosome abnormalities. This test uses pyrosequencing to quantitate relative allele strength (RAS) from single-nucleotide polymorphisms using 18 informative single-nucleotide polymorphisms markers that span the X-chromosome and one marker for the detection of Y-chromosome material. RESULTS: Cutoff ranges for heterozygous, homozygous, or out-of-range RAS values were established from a cohort of 496 males and females. Positive TS scoring criteria were defined as the presence of homozygosity for all 18 markers or the presence of at least one out-of-range RAS value. To determine the validity of this rapid test for TS detection, we undertook a large-scale study using DNA from 132 females without TS and 74 females with TS for whom karyotypes were available. TS was identified with 96.0% sensitivity and 97.0% specificity in this cohort. We also tested buccal swab DNA from a group of 19 females without TS and 69 females with TS. In this group, TS was identified with 97.1% sensitivity and 84.2% specificity. CONCLUSIONS: These results demonstrate the validity of a high-throughput, pyrosequencing based test for the accurate detection of TS, providing a potential alternative to karyotype testing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-1554

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several molecular methods have been proposed for neonatal screening of TS, the most promising of which thus far are pyrosequencing and real-time PCR.

    “Alternatively, several molecular methods have been proposed for neonatal screening of TS, the most promising of which thus far are pyrosequencing and real-time PCR.89”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rivkees, S. A., Hager, K., Hosono, S., Wise, A., Li, P., Rinder, H. M., & Gruen, J. R.
Affiliations
  • Yale University (US)
  • JS Genetics (United States) (US)
Corresponding author
Rivkees, Scott A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-03-01
Volume
96
Issue
3
Pages
699-705
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2045253224
Cited by
28
References
27
Citations by year
2026: 1 · 2024: 2 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 5 · 2012: 3
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R42HD049230)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
Turner syndrome, X chromosome deletion, pyrosequencing, SNP markers, buccal swab DNA, early diagnosis, growth hormone therapy, sensitivity and specificity
MeSH terms
Alleles, DNA, Female, Genotype, Homozygote, Humans, Karyotyping, Male, Mouth Mucosa, Turner Syndrome, Reproducibility of Results, Cohort Studies, Polymorphism, Single Nucleotide, Chromosomes, Human, X, Chromosomes, Human, Y, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review